Shares of Ingevity Corporation (NYSE:NGVT – Get Free Report) have been given a consensus rating of “Hold” by the five brokerages that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and two have issued a buy recommendation on the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is $80.00.
Several equities analysts recently commented on NGVT shares. Jefferies Financial Group reiterated a “buy” rating and set a $82.00 target price on shares of Ingevity in a research note on Thursday, February 26th. Zacks Research raised shares of Ingevity to a “hold” rating in a research report on Tuesday, December 16th. Wells Fargo & Company increased their target price on shares of Ingevity from $65.00 to $75.00 and gave the company an “equal weight” rating in a research note on Friday, February 27th. BMO Capital Markets reaffirmed an “outperform” rating and issued a $83.00 target price on shares of Ingevity in a research report on Monday, March 2nd. Finally, Wall Street Zen downgraded shares of Ingevity from a “strong-buy” rating to a “buy” rating in a research note on Monday, March 9th.
View Our Latest Report on Ingevity
Institutional Trading of Ingevity
Ingevity Price Performance
NYSE NGVT opened at $63.54 on Monday. The stock has a 50-day simple moving average of $68.95 and a 200 day simple moving average of $60.23. Ingevity has a twelve month low of $28.49 and a twelve month high of $77.46. The stock has a market capitalization of $2.24 billion, a PE ratio of -13.66 and a beta of 1.31. The company has a debt-to-equity ratio of 39.10, a quick ratio of 0.79 and a current ratio of 1.33.
Ingevity (NYSE:NGVT – Get Free Report) last released its earnings results on Wednesday, February 25th. The company reported $0.58 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.74 by ($0.16). Ingevity had a negative net margin of 13.51% and a positive return on equity of 126.25%. The business had revenue of $255.10 million during the quarter, compared to analyst estimates of $257.27 million. During the same period last year, the business earned $0.95 EPS. The business’s quarterly revenue was down 3.2% compared to the same quarter last year. Ingevity has set its FY 2026 guidance at 4.800-5.20 EPS. Research analysts anticipate that Ingevity will post 4.45 EPS for the current year.
Ingevity Company Profile
Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.
The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.
Featured Articles
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.
